{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:30:06Z","timestamp":1782397806097,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21502225"],"award-info":[{"award-number":["21502225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30872120\/H2603"],"award-info":[{"award-number":["30872120\/H2603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Shanghai Pujiang Talent program","award":["17PJD042"],"award-info":[{"award-number":["17PJD042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11010-018-3341-9","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T08:48:22Z","timestamp":1520844502000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K\/AKT signaling pathways"],"prefix":"10.1007","volume":"449","author":[{"given":"Xiao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bin","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"issue":"8","key":"3341_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5732\/cjc.014.10088","volume":"33","author":"KR Wei","year":"2014","unstructured":"Wei KR, Yu X, Zheng RS, Peng XB, Zhang SW, Ji MF, Liang ZH, Ou ZX, Chen WQ (2014) Incidence and mortality of liver cancer in China, 2010. Chin J Cancer 33(8):388. \n                    https:\/\/doi.org\/10.5732\/cjc.014.10088","journal-title":"Chin J Cancer"},{"key":"3341_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-642-16037-0_15","volume":"190","author":"C Ang","year":"2013","unstructured":"Ang C, O\u2019Reilly EM, Abou-Alfa GK (2013) Targeted agents and systemic therapy in hepatocellular carcinoma. Recent Results Cancer Res 190:225\u2013246. \n                    https:\/\/doi.org\/10.1007\/978-3-642-16037-0_15","journal-title":"Recent Results Cancer Res"},{"issue":"6","key":"3341_CR3","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1007\/s13277-014-1680-z","volume":"35","author":"Y Liu","year":"2014","unstructured":"Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q, Su C (2014) Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol 35(6):5111\u20135119. \n                    https:\/\/doi.org\/10.1007\/s13277-014-1680-z","journal-title":"Tumour Biol"},{"issue":"31","key":"3341_CR4","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.3748\/wjg.v18.i31.4199","volume":"18","author":"NL Chai","year":"2012","unstructured":"Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP, Wu BY (2012) Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells. World J Gastroenterol 18(31):4199. \n                    https:\/\/doi.org\/10.3748\/wjg.v18.i31.4199","journal-title":"World J Gastroenterol"},{"issue":"9","key":"3341_CR5","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.3390\/molecules170910370","volume":"17","author":"Y Yang","year":"2012","unstructured":"Yang Y, Xiu J, Zhang X, Zhang L, Yan K, Qin C, Liu J (2012) Antiviral effect of matrine against human enterovirus 71. Molecules 17(9):10370\u201310376. \n                    https:\/\/doi.org\/10.3390\/molecules170910370","journal-title":"Molecules"},{"issue":"13\u201314","key":"3341_CR6","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.intimp.2008.08.008","volume":"8","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Wang S, Li Y, Xiao Z, Hu Z, Zhang J (2008) Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. Int Immunopharmacol 8(13\u201314):1767\u20131772. \n                    https:\/\/doi.org\/10.1016\/j.intimp.2008.08.008","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"3341_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1365-4632.2008.03627.x","volume":"47","author":"XY1 Liu","year":"2008","unstructured":"Liu XY1, Fang H, Yang ZG, Wang XY, Ruan LM, Fang DR, Ding YG, Wang YN, Zhang Y, Jiang XL, Chen HC (2008) Matrine inhibits invasiveness and metastasis of human malignant melanoma cell line A375 in vitro. Int J Dermatol 47(5):448\u2013456. \n                    https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03627.x","journal-title":"Int J Dermatol"},{"issue":"1","key":"3341_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2015.07.035","volume":"368","author":"L Qian","year":"2015","unstructured":"Qian L, Liu Y, Xu Y, Ji W, Wu Q, Liu Y, Gao Q, Su C (2015) Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR\/ERK\/MMP-2 and PTEN\/AKT signaling pathways. Cancer Lett 368(1):126\u201334. \n                    https:\/\/doi.org\/10.1016\/j.canlet.2015.07.035","journal-title":"Cancer Lett"},{"issue":"1","key":"3341_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/aps.2016.104","volume":"38","author":"Y Liu","year":"2016","unstructured":"Liu Y, Qi Y, Bai ZH, Ni CX, Ren QH, Xu WH, Xu J, Hu HG, Qiu L, Li JZ, He ZG, Zhang JP (2016) A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K\/AKT signaling pathways. Acta Pharmacol Sin 38(1):120\u2013132. \n                    https:\/\/doi.org\/10.1038\/aps.2016.104","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"3341_CR10","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0145-2126(00)00145-4","volume":"25","author":"LP Zhang","year":"2001","unstructured":"Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, Liu BZ, He YJ (2001) Effects of matrine on proliferation and differentiation in K-562 cells. Leuk Res 25(9):793\u2013800","journal-title":"Leuk Res"},{"issue":"1\u20133","key":"3341_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejphar.2007.01.073","volume":"563","author":"L Zhang","year":"2007","unstructured":"Zhang L, Wang T, Wen X, Wei Y, Peng X, Li H, Wei L (2007) Effect of matrine on HeLa cell adhesion and migration. Eur J Pharmacol 563(1\u20133):69\u201376","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"3341_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1055\/s-2006-931534","volume":"72","author":"XS Liu","year":"2006","unstructured":"Liu XS, Jiang J, Jiao XY, Wu YE, Lin JH (2006) Matrine-induced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways. Planta Med 72(6):501\u2013506","journal-title":"Planta Med"},{"issue":"2\u20133","key":"3341_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejphar.2006.12.017","volume":"559","author":"H Jiang","year":"2007","unstructured":"Jiang H, Hou C, Zhang S, Xie H, Zhou W, Jin Q, Cheng X, Qian R, Zhang X. (2007) Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. Eur J Pharmacol 559(2\u20133):98\u2013108","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"3341_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11033-008-9247-y","volume":"36","author":"S Zhang","year":"2009","unstructured":"Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou M, Sun X (2009) Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Mol Biol Rep 36(4):791\u2013799. \n                    https:\/\/doi.org\/10.1007\/s11033-008-9247-y","journal-title":"Mol Biol Rep"},{"issue":"7","key":"3341_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129(7):1261\u20131274","journal-title":"Cell"},{"issue":"1","key":"3341_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/156800908783497104","volume":"8","author":"GZ Cheng","year":"2008","unstructured":"Cheng GZ, Park S, Shu S, He L, Kong W, Zhang W, Yuan Z, Wang LH, Cheng JQ (2008) Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8(1):2\u20136","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"3341_CR17","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1074\/jbc.M413104200","volume":"280","author":"P Voigt","year":"2005","unstructured":"Voigt P, Brock C, N\u00fcrnberg B, Schaefer M (2005) Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase gamma. J Biol Chem 280(6):5121\u20135127","journal-title":"J Biol Chem"},{"issue":"2","key":"3341_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","volume":"107","author":"N Embi","year":"1980","unstructured":"Embi N, Rylatt DB, Cohen P (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107(2):519\u2013527","journal-title":"Eur J Biochem"},{"issue":"3","key":"3341_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1006\/prep.2000.1321","volume":"20","author":"A Primot","year":"2000","unstructured":"Primot A, Baratte B, Gompel M, Borgne A, Liabeuf S, Romette JL, Jho EH, Costantini F, Meijer L (2000) Purification of GSK-3 by affinity chromatography on immobilized axin. Protein Expr Purif 20(3):394\u2013404","journal-title":"Protein Expr Purif"},{"issue":"44","key":"3341_CR20","doi-asserted-by":"publisher","first-page":"34266","DOI":"10.1074\/jbc.M006160200","volume":"275","author":"RJ Crowder","year":"2000","unstructured":"Crowder RJ, Freeman RS (2000) Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275(44):34266\u201334271","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"3341_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20050282","volume":"391","author":"M Bianchi","year":"2005","unstructured":"Bianchi M, De Lucchini S, Marin O, Turner DL, Hanks SK, Villa-Moruzzi E (2005) Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration. Biochem J 391(Pt 2):359\u2013370","journal-title":"Biochem J"},{"issue":"4","key":"3341_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4161\/cc.2.4.433","volume":"2","author":"J Liang","year":"2003","unstructured":"Liang J, Slingerland JM (2003) Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2(4):339\u2013345","journal-title":"Cell Cycle"},{"issue":"13","key":"3341_CR23","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.1074\/jbc.M109062200","volume":"277","author":"Y Li","year":"2001","unstructured":"Li Y, Dowbenko D, Lasky LA (2001) AKT\/PKB phosphorylation of p21Cip\/WAF1 enhances protein stability of p21Cip\/WAF1 and promotes cell survival. J Biol Chem 277(13):11352\u201311361","journal-title":"J Biol Chem"},{"issue":"2","key":"3341_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4132\/KoreanJPathol.2013.47.2.107","volume":"47","author":"W Hwangbo","year":"2013","unstructured":"Hwangbo W, Lee JH, Ahn S, Kim S, Park KH, Kim CH, Kim I (2013) EGFR gene amplification and protein expression in invasive ductal carcinoma of the breast. Korean J Pathol 47(2):107. \n                    https:\/\/doi.org\/10.4132\/KoreanJPathol.2013.47.2.107","journal-title":"Korean J Pathol"},{"issue":"2","key":"3341_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12017-013-8229-y","volume":"15","author":"B Kalman","year":"2013","unstructured":"Kalman B, Szep E, Garzuly F, Post DE (2013) Epidermal growth factor receptor as a therapeutic target in glioblastoma. Neuromolecular Med 15(2):420\u2013434. \n                    https:\/\/doi.org\/10.1007\/s12017-013-8229-y","journal-title":"Neuromolecular Med"},{"issue":"6","key":"3341_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.amjsurg.2007.05.061","volume":"195","author":"T Colakoglu","year":"2008","unstructured":"Colakoglu T, Yildirim S, Kayaselcuk F, Nursal TZ, Ezer A, Noyan T, Karakayali H, Haberal M (2008) Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase\/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg 195(6):719\u2013725. \n                    https:\/\/doi.org\/10.1016\/j.amjsurg.2007.05.061","journal-title":"Am J Surg"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-018-3341-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-018-3341-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T20:09:51Z","timestamp":1552334991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-018-3341-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3341"],"URL":"https:\/\/doi.org\/10.1007\/s11010-018-3341-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"26 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}